Fabrinet vs Lumentum
FN and LITE side by side, both in communications equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FN and LITE compare
Lumentum is the larger company, worth 6.4 times as much as Fabrinet ($75.4B against $11.7B).
Lumentum grew revenue faster over the last twelve months (83.2% versus 35.7% for Fabrinet).
Fabrinet keeps more of each dollar of sales as profit, with a net margin of 10.2% compared with −230% at Lumentum.
Fabrinet scores higher on the StockData Score (19 against 8 for Lumentum), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FN | LITE |
|---|---|---|
| Size and price | ||
| Market cap | $11.7B | $75.4B |
| Share price | $327.29 | $840.70 |
| Change, 1 year | −26.3% | 292% |
| Change, 5 years | 172% | 801% |
| Beta (5Y) | 1.60 | 1.72 |
| Employees | 22K | 14K |
| StockData Score | ||
| Total score | 19 (better) | 8 |
| Valuation score | 3 (better) | 0 |
| Growth score | 4 (better) | 3 |
| Performance score | 6 (better) | 1 |
| Health score | 6 (better) | 4 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 25.1× | – |
| P/S | 2.5× (better) | 25.0× |
| P/B | 4.8× (better) | 16.2× |
| EV/EBITDA | 20.4× (better) | 145× |
| P/FCF | 2778× | 251× (better) |
| PEG | 1.02 | – |
| FCF yield | 0.04% | 0.40% (better) |
| Fair value | $355.77 | $138.79 |
| Margin of safety | 8.0% (better) | −506% |
| Growth | ||
| Revenue growth (TTM) | 35.7% | 83.2% (better) |
| Revenue growth, 5Y average | 19.8% (better) | 11.6% |
| Net income growth (TTM) | 42.3% (better) | −26876% |
| EPS growth (TTM) | 42.3% | – |
| EPS growth, 5Y average | 27.0% | – |
| Profitability | ||
| Gross margin | 12.0% | 41.7% (better) |
| Operating margin | 10.0% | 17.4% (better) |
| Net margin | 10.2% (better) | −230% |
| FCF margin | 0.09% | 10.0% (better) |
| Return on equity | 21.3% (better) | −240% |
| Return on invested capital | 30.0% (better) | 10.4% |
| Financial health | ||
| Debt / equity | 0.00 | 0.70 (better) |
| Net debt / EBITDA | – | 0.94 |
| Interest coverage | – | 24.1× |
| Current ratio | 2.25 (better) | 1.68 |
| Altman Z-score | 7.87 | 16.42 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Buyback yield | 0.04% | – |
| Shareholder yield | 0.04% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 102% | 91.8% |
| Held by insiders | 0.52% | 1.0% |
| Insider net buying, 12 months | −$17.0M (better) | −$150M |
| Superinvestors holding | 2 (better) | 1 |
| Short interest, % of float | 4.6% | 8.4% |
Go deeper
- FN stock overview
- FN income statement
- FN valuation and score
- LITE stock overview
- LITE income statement
- LITE valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.